Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Salvador-Martín S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Torres-Peral R, Rodríguez A, Bossacoma F, Merino-Bohórquez V, Salcedo E, Álvarez R, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: rubbini g. Biomed Pharmacother. 2024 Apr;173:116299. doi: 10.1016/j.biopha.2024.116299. Epub 2024 Feb 23. Biomed Pharmacother. 2024. PMID: 38401525 Free article.
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.
Luque-Navarro PM, Mariotto E, Ballarotto M, Rubbini G, Aguilar-Troyano FJ, Fasiolo A, Torretta A, Parisini E, Macchiarulo A, Laso A, Marco C, Viola G, Carrasco-Jimenez MP, López-Cara LC. Luque-Navarro PM, et al. Among authors: rubbini g. Pharmaceutics. 2022 Mar 27;14(4):715. doi: 10.3390/pharmaceutics14040715. Pharmaceutics. 2022. PMID: 35456549 Free PMC article.
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity.
Aguilar-Troyano FJ, Torretta A, Rubbini G, Fasiolo A, Luque-Navarro PM, Carrasco-Jimenez MP, Pérez-Moreno G, Bosch-Navarrete C, González-Pacanowska D, Parisini E, Lopez-Cara LC. Aguilar-Troyano FJ, et al. Among authors: rubbini g. Pharmaceutics. 2021 Nov 2;13(11):1842. doi: 10.3390/pharmaceutics13111842. Pharmaceutics. 2021. PMID: 34834257 Free PMC article.
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
Rubbini G, Buades-Martín AB, Kimatrai-Salvador M, Entrena A, Gallo-Mezo MÁ, Ríos-Marco P, Marco C, Mattiuzzo E, Bortolozzi R, Mariotto E, Greco FA, Macchiarulo A, Carrasco-Jiménez MP, Viola G, López-Cara LC. Rubbini G, et al. Future Med Chem. 2018 Aug 1;10(15):1769-1786. doi: 10.4155/fmc-2018-0059. Epub 2018 Jul 25. Future Med Chem. 2018. PMID: 30043647
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.
Serrán-Aguilera L, Mariotto E, Rubbini G, Castro Navas FF, Marco C, Carrasco-Jiménez MP, Ballarotto M, Macchiarulo A, Hurtado-Guerrero R, Viola G, Lopez-Cara LC. Serrán-Aguilera L, et al. Among authors: rubbini g. Eur J Med Chem. 2020 Dec 1;207:112797. doi: 10.1016/j.ejmech.2020.112797. Epub 2020 Sep 6. Eur J Med Chem. 2020. PMID: 32977218